GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2018-2026

The Global Allergy diagnostic and treatment market is anticipated to grow at a CAGR of 5.50% between 2018 and 2026. Allergies are abnormal responses by the immune system to specific allergens (e.g., foods, pollen mould, and animal dander). The Allergy diagnostic and treatment market is primarily driven by the following factors:

  • High incidences and large economic burden of allergic diseases
  • Rising environmental pollution
  • Growing use of tobacco
  • Presence of high unmet medical needs

Allergy Diagnostics & Treatment Market

To learn more about this report, request a free sample copy

The important drivers increasing growth in the Global Allergy diagnostic and treatment market is the high incidence and large economic burden of allergic diseases, coupled with the rising environmental pollution. The growth in industrialization causes an increase in pollution of air as well as a rise in a variety of air pollutants. Due to this, the allergic diseases are a more challenging field and more diverted. The common allergies observed in the world are Allergic Rhinitis, Drug Allergy, Food Allergy, Insect Allergy, Skin allergy, General Allergy, etc.

Treatments, Diagnostics, and Immunotherapy are the major segments based on which this market is segmented. The treatment market by availability comprises of Prescription and Over the Counter. The Prescription involves Symptomatic treatments to treat different stages of the allergic symptoms. The treatment market by administration comprises of Oral, Spray, Ocular, and Topical. The Oral administrations are widely used and are anticipated to grow significantly. Oral immunotherapy, also acknowledged as oral desensitization, is a way of persuading the body’s immune system to bear food that causes an allergic reaction. Alocril is an ocular drug that stabilizes and prevents actions from eosinophils and neutrophils and prevents neuronal actions. The Diagnostic segment comprises of Skin Testing and Antibody. The most prevalent type of allergy testing remains skin prick tests. For the sublingual immunotherapy approach, an allergist must confirm a patient’s sensitivity to an allergen through traditional allergy testing.

Adverse effects of drugs and lack of awareness about allergic diseases are the major factors hindering the Allergy diagnostic and treatment market. The difference between allergy and intolerance is unknown to the normal people. Also, there is a lack of awareness amongst the people about allergies. Certain allergic drugs can have adverse effects, ex: drugs for allergic rhinitis can cause harm to the nasal passages, nose bleeds, nasal irritation, watery eyes, itchy nose and throat, insomnia, and dizziness.

The Global Allergy diagnostic and treatment market segments include Treatments, Diagnostics, and Immunotherapy. They are further segmented as follows:-

  • Treatments
    • Treatment market by the availability
    • Prescription
    • Over the counter
    • Treatment market by the administration
    • Oral
    • Spray
    • Ocular
    • Topical
    • Treatment market by-products
    • Antihistamines
    • Sympathomimetic, decongestants and combinations
    • Corticosteroids
    • Leukotriene
    • Mast cell stabilizers
  • Diagnostics
    • Skin testing
    • Antibody
  • Immunotherapy
    • Subcutaneous administration
    • Sublingual liquid solutions
    • Sublingual tablets

This report covers the present market conditions and the growth prospects of the Global Allergy diagnostic and treatment market for 2018-2026 and considered the revenue generated through the sales of Allergy diagnostic and treatments for Treatment, Diagnostics, and Immunotherapy to calculate the market size by considering 2017 as the base year.

Geographically, the Global Allergy diagnostic and treatments market has been segmented into four major regions, which include:

  • North America: The U.S. & Canada
  • Asia-Pacific: China, India, Japan, Australia & New Zealand & Rest of APAC
  • Europe: The United Kingdom, France, Germany, Russia & Rest of Europe
  • Rest of World: Latin America & Middle East and Africa

The Allergy diagnostic and treatment market in North America is expected to hold the largest share by 2026 owing to the growing competition from generics in the oral antihistamines and intranasal corticosteroid segments. However, there are also opportunities for the expansion of the immunotherapy segment in emerging markets. Allergies are the 6th leading cause of chronic illness. In the U.S, Allergic conditions are the most common health issues affecting children. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the Allergic diagnostic and treatment . The market in APAC is expected to grow rapidly due to the increased healthcare spending in this region. Also, major growth opportunities may be created in countries such as China, Japan, and India because of the healthcare investments by the government of these respective countries and increased out-of-pocket expenditure by residing population.

The major market players of the global Allergy diagnostic and treatment market are:

  • Allergan Plc
  • Beckman Coulter
  • Hitachi Chemical Diagnostics Inc.
  • Johnson & Johnson
  • Pfizer

Company Profiles covers analysis of important players.

Allergan PLC is a global pharmaceutical company established on 18th Feb 2015, by Allen Chao and David Hsia. It is headquarters in Dublin, Ireland. In June 2015, it was acquired by Actavis, PLC.  Pfizer is another of the world’s largest research-based biomedical and pharmaceutical company, with its corporate headquarters situated in New York City and research headquarter in Groton, Connecticut. The company always tries to deliver innovative therapies that extend and significantly improve lives.

Key Findings of the Global Allergy Diagnostic and Treatment market:

  • Allergic conjunctivitis is becoming increasingly prevalent
  • Skin prick test is the most prevalent type of allergy testing
  • Antihistamines treatment holds the largest market share

TABLE OF CONTENTS
  1. RESEARCH SCOPE
    1. STUDY GOALS
    2. SCOPE OF THE MARKET STUDY
    3. WHO WILL FIND THIS REPORT USEFUL?
    4. STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    1. SOURCES OF DATA
      1. SECONDARY DATA
      2. PRIMARY DATA
    2. TOP DOWN APPROACH
    3. BOTTOM-UP APPROACH
    4. DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    1. MARKET SUMMARY
    2. KEY FINDINGS
      1. ALLERGIC CONJUNCTIVITIS IS BECOMING INCREASINGLY PREVALENT
      2. SKIN PRICK TEST IS THE MOST PREVALENT TYPE OF ALLERGY TESTING
      3. ANTIHISTAMINES TREATMENT HOLDS THE LARGEST MARKET SHARE
  4. MARKET DETERMINANTS
    1. MARKET DRIVERS
      1. HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
      2. RISING ENVIRONMENTAL POLLUTION
      3. HIGH USE OF TOBACCO
      4. PRESENCE OF HIGH UNMET MEDICAL NEEDS
    2. MARKET RESTRAINTS
      1. STRINGENT REGULATIONS FOR MEDICAL DEVICES
      2. LACK OF AWARENESS ABOUT ALLERGIC DISEASES
      3. HIGH CAPITAL REQUIREMENTS
      4. HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
      5. ADVERSE EFFECTS OF DRUGS
    3. MARKET OPPORTUNITIES
      1. ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES
      2. RISE IN AWARENESS ABOUT ALLERGIC RHINITIS
    4. MARKET CHALLENGES
      1. ALTERNATE THERAPIES AND DRUGS
      2. EASY AVAILABILITY OF GENERIC DRUGS
      3. INCREASING HEALTHCARE EXPENDITURE
      4. PATENT EXPIRIES AND COMPETITION FROM GENERIC DRUGS
  5. MARKET SEGMENTATION
    1. MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026
      1. TREATMENTS
        1. TREATMENT MARKET BY AVAILABILITY
          1. PRESCRIPTION
          2. OVER THE COUNTER
        2. TREATMENT MARKET BY ADMINISTRATION
          1. ORAL
          2. SPRAY
          3. OCULAR
          4. TOPICAL
        3. TREATMENT MARKET BY PRODUCTS
          1. ANTIHISTAMINES
          2. SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS
          3. CORTICOSTEROIDS
          4. LEUKOTRIENES
          5. MAST CELL STABILIZERS
      2. DIAGNOSTICS
        1. SKIN TESTING
        2. ANTIBODY
      3. IMMUNOTHERAPY
        1. SUBCUTANEOUS ADMINISTRATION
        2. SUBLINGUAL LIQUID SOLUTIONS
        3. SUBLINGUAL TABLETS
  6. KEY ANALYTICS
    1. PORTERS FIVE FORCE ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF BUYERS
      4. BARGAINING POWER OF SUPPLIERS
      5. THREAT OF RIVALRY
    2. KEY BUYING CRITERIA
    3. SUPPLY CHAIN ANALYSIS
    4. PATENT ANALYSIS
  7. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. THE UNITED STATES
      2. CANADA
    2. EUROPE
      1. GERMANY
      2. FRANCE
      3. THE UK
      4. RUSSIA
      5. REST OF EUROPE
    3. ASIA-PACIFIC
      1. INDIA
      2. CHINA
      3. JAPAN
      4. AUSTRALIA AND NEW ZEALAND
      5. REST OF APAC
    4. REST OF WORLD
      1. MIDDLE EAST AND AFRICA
      2. LATIN AMERICA
  8. COMPANY PROFILES
    1. ALLERGAN PLC
      1. COMPANY OVERVIEW
      2. PRODUCTION PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVE
    2. BECKMAN COULTER
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    3. GLAXOSMITHKLINE PLC
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    4. HITACHI CHEMICAL DIAGNOSTICS INC.
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    5. JOHNSON & JOHNSON
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    6. MERCK
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC MOVES
    7. PFIZER
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    8. SANOFI
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    9. THERMO FISHER DIAGNOSTICS
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    10. HOFFMANN-LA ROCHE LTD
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES
    11. MYLAN N.V.
      1. COMPANY OVERVIEW
      2. PRODUCT PORTFOLIO
      3. SCOT ANALYSIS
      4. STRATEGIC INITIATIVES

 

LIST OF TABLES

TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 2 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026 ($ MILLION)

TABLE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY AVAILABILITY 2018-2026 ($ MILLION)

TABLE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY ADMINISTRATION 2018-2026 ($ MILLION)

TABLE 5 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY PRODUCTS 2018-2026 ($ MILLION)

TABLE 6 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN DIAGNOSTICS 2018-2026 ($ MILLION)

TABLE 7 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN IMMUNOTHERAPY 2018-2026 ($ MILLION)

TABLE 8 NORTH AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

TABLE 9 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

TABLE 10 ASIA PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

TABLE 11 REST OF THE WORLD ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 2 GLOBAL TREATMENTS MARKET IN PRESCRIPTION 2018-2026 ($ MILLION)

FIGURE 3 GLOBAL TREATMENTS MARKET IN OVER THE COUNTER 2018-2026 ($ MILLION)

FIGURE 4 GLOBAL TREATMENTS MARKET IN ORAL 2018-2026 ($ MILLION)

FIGURE 5 GLOBAL TREATMENTS MARKET IN SPRAY 2018-2026 ($ MILLION)

FIGURE 6 GLOBAL TREATMENTS MARKET IN OCULAR 2018-2026 ($ MILLION)

FIGURE 7 GLOBAL TREATMENTS MARKET IN TOPICAL 2018-2026 ($ MILLION)

FIGURE 8 GLOBAL TREATMENTS MARKET IN ANTIHISTAMINES 2018-2026 ($ MILLION)

FIGURE 9 GLOBAL TREATMENTS MARKET IN SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS 2018-2026 ($ MILLION)

FIGURE 10 GLOBAL TREATMENTS MARKET IN CORTICOSTEROIDS 2018-2026 ($ MILLION)

FIGURE 11 GLOBAL TREATMENTS MARKET IN LEUKOTRIENES 2018-2026 ($ MILLION)

FIGURE 12 GLOBAL TREATMENTS MARKET IN MAST CELL STABILIZERS 2018-2026 ($ MILLION)

FIGURE 13 GLOBAL DIAGNOSTICS MARKET IN SKIN TESTING 2018-2026 ($ MILLION)

FIGURE 14 GLOBAL TREATMENTS MARKET IN ANTIBODY 2018-2026 ($ MILLION)

FIGURE 15 GLOBAL TREATMENTS MARKET IN SUBCUTANEOUS ADMINISTRATION 2018-2026 ($ MILLION)

FIGURE 16 GLOBAL TREATMENTS MARKET IN SUBLINGUAL LIQUID SOLUTIONS 2018-2026 ($ MILLION)

FIGURE 17 GLOBAL TREATMENTS MARKET IN SUBLINGUAL TABLETS 2018-2026 ($ MILLION)

FIGURE 18 KEY BUYING CRITERIA OF ALLERGY DIAGNOSTICS AND TREATMENT MARKET

FIGURE 19 THE UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 20 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 21 PERCENTAGE OF PEOPLE SUFFERING FROM SEVERE FOOD ALLERGY IN CANADA 2017

FIGURE 22 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 23 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 24 THE UNITED KINGDOM ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 25 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 26 REST OF EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 27 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 28 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 29 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 30 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 31 REST OF APAC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 32 MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

FIGURE 33 LATIN AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

Request For A Free Sample